Imported-post
-
Study explores concussion recovery by race
Vanderbilt researchers are exploring the outcomes and experiences of Black and White athletes following a sports-related concussion. Read MoreSeptember 23, 2021
-
Team awarded $2.3 million NIH grant to evaluate new, more accurate ultrasound methods
New acquisition and reconstruction solutions for ultrasound imaging developed by a Vanderbilt team aim to fundamentally improve the ability to obtain high quality, clinically relevant images, especially in cases of heart disease. With a new, $2.3 million National Institutes of Health grant, the researchers will evaluate their advances on a specific subset of cardiac imaging... Read MoreSeptember 9, 2021
-
$1.9 million NIH project to investigate effects of shear stress on cancer cells
A biomedical engineering professor has received a $1.9 million NIH grant to investigate the effects of mechanical stimuli such as shear stress on the behavior of cancer cells in blood flow. J. Lawrence Wilson Professor Mike King and his research group will develop the devices for the study as well as new cell lines to... Read MoreSeptember 9, 2021
-
Landmark study examines decarbonization of U.S. inland waterways
Sept. 23 webinar to cover challenges, options for inland fleet A landmark new report by Vanderbilt transportation and environmental engineers looks toward decarbonization of U.S. waterways and evaluates the potential for possible future propulsion technologies and alternative fuels to reduce carbon emissions. The comprehensive study, the first to examine the U.S. inland waterway system through... Read MoreSeptember 7, 2021
-
White matter and schizophrenia
Patients with schizophrenia have functional changes in the white matter of the brain, Vanderbilt researchers have discovered, which may contribute to impaired working memory and processing speed. Read MoreSeptember 2, 2021
-
Rheumatoid arthritis drug combined with standard of care may help reduce mortality for hospitalized COVID-19 patients
Hospitalized patients with COVID-19 who received the rheumatoid arthritis drug baricitinib, in combination with the standard of care including corticosteroids, died less often than those receiving only the standard of care, according to a study released this week. Read MoreSeptember 2, 2021
-
Discovery offers insight for development of cancer therapies targeting mutant p53
The tumor suppressor protein p53 is mutated in more than half of all human cancers. Several drugs that potentially can restore mutant p53 to its normal cancer-killing function are in clinical investigation. Read MoreSeptember 2, 2021
-
Engineering doctoral students experience paradigm-shifting clinical training in surgery and intervention
Trainees gain big picture knowledge plus work closely with surgeons The results are in: Five cohorts of Vanderbilt engineering doctoral students have experienced ‘paradigm-shifting training’ in surgery and intervention. Preliminary reports from a five-year program of intensive training, supported by a nearly $1 million National Institute of Biomedical Imaging and Bioengineering grant, show strong evidence... Read MoreAugust 27, 2021
-
Team isolates antibodies that target alphaviruses
A multi-institutional team led by researchers at Vanderbilt University Medical Center has isolated monoclonal antibodies that prevent infection by alphaviruses, including the often-lethal Eastern equine encephalitis virus. Read MoreAugust 19, 2021
-
Potential protection from atherosclerosis
Vanderbilt researchers have discovered a potential way to reduce atherosclerosis: blocking the modification of an HDL-associated enzyme by reactive molecules called isolevuglandins. Read MoreAugust 19, 2021